July 9 (SeeNews) - The European Commission said on Wednesday Slovenian blue-chip drug maker Krka [LJE:KRKG] is among five generic companies that have been fined alongside French pharmaceutical firm Servier for curbing the market entry of cheaper versions of a cardiovascular medicine.